Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Nacon SAS
PAR:NACON
|
FR |
|
Blackstone Mortgage Trust Inc
NYSE:BXMT
|
US |
|
Zai Lab Ltd
HKEX:9688
|
CN |
|
Delta Lithium Ltd
ASX:DLI
|
AU |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
J
|
Jones Lang LaSalle Inc
XBER:4J2
|
US |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
Marsh & McLennan Companies Inc
NYSE:MMC
|
US |
|
Resmed Inc
OTC:RSMDF
|
US |
|
T
|
TriMas Corp
NASDAQ:TRS
|
US |
|
Japan Excellent Inc
TSE:8987
|
JP |
|
Ardelyx Inc
NASDAQ:ARDX
|
US |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
Daehan Shipbuilding Co Ltd
KRX:439260
|
KR |
|
Bridgepoint Group PLC
LSE:BPT
|
UK |
|
Kinarus Therapeutics Holding AG
SIX:KNRS
|
CH |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
Carter's Inc
NYSE:CRI
|
US |
|
B
|
Barrick Gold Corp
LSE:0R22
|
CA |
|
Somero Enterprises Inc
LSE:SOM
|
US |
|
D
|
Deep Yellow Ltd
XMUN:JMI
|
AU |
|
Lithia Motors Inc
NYSE:LAD
|
US |
Multiples-Based Value
The Multiples-Based Value for
Biomarin Pharmaceutical Inc (BMRN) under the Base Case is hidden
USD.
Compared with the current market price of 57.29 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.